Ludwig-Maximilians-Universität
Koeniginstr. 16
80539 Munich
Germany
|
Prof. Dr. Heidrun Potschka Workpackage leader Phone: +49-(0)89-2180-2662 Fax: +49-(0)89-2180-16556 |
|
Prof. Dr. Peter Bartenstein Head of the Clinic for Nuclear Medicine Phone: +49-(0)89-7095-4610 Fax: +49-(0)89-7095-4648 |
|
Mr. Hero Bartmann Scientist (epilepsy models) Phone: +49-(0)89-2180-3873 |
|
Dr. rer. nat. Guido Boening Project management (PET acquisition) – radiation safety Phone: +49-(0)89- 7095-4657 |
|
PhD Paul Cumming Project management (PET modelling) Phone: +49-(0)89- 7095-4646 |
|
Christina Fuest Project management (epilepsy models) and coordination Phone: +49-(0)89-2180-3264 |
|
Dipl. Chem. Dr. rer. medic. Franz-Josef Gildehaus Radiochemistry – animal care officer Phone: +49-(0)89- 7095-4645 |
|
Dr. Christian La Fougere Project management (PET) – coordination Phone: +49-(0)89- 7095-4646 |
|
Mr. Sebastian Nowak PET scan acquisition Phone: +49-(0)89- 7095-7617 |
|
PhD Dr. Anton Pekcec Project management (epilepsy models) Phone: +49-(0)89-2180-3264 |
|
Dipl. Chem. Dr. rer. nat. Bjoern Waengler Project management (radiochemistry) Phone: +49-(0)89- 7095-4657 |
|
Dipl. Biol. Erika Wagner Scientist – animal handling Phone: +49-(0)89- 7095-4615 |
In the Clinic for Nuclear Medicine of the Medical Faculty profound experience exists in radioligand synthesis and preclinical evaluation of radiopharmaceuticals including cell binding studies and autoradiography, PET imaging of receptor-ligand interaction including modeling and various voxel-wise quantification approaches in humans and rodents. The assessment of the action of various psychotropic drugs with PET has been another focus. The basic science oriented methodology group is embedded in Germanys largest clinical Nuclear medicine department equipped with PET-CT, 2 dedicated PET-cameras, suitable for neuro-imaging and several 2 and 3 headed SPECT-cameras and has facilities for radiotracer synthesis, cell culture and an animal PET-camera.
In the Institute of Pharmacology, Toxicology, and Pharmacy of the Faculty of Veterinary Medicine profound expertise exists in a variety of epilepsy models, and in neuropharmacological studies. Research during the last years contributed significantly to the characterization of multidrug transporters including their substrate specificity, their modulation, expression regulation, and contribution to pharmacoresistance of epilepsy. The group currently develops different innovative approaches to overcome transporter-mediated pharmacoresistance. Recent studies of the group elucidated the signaling pathways involved in the regulation of the multidrug transporter P-glycoprotein in capillary endothelial cells of the epileptic brain. Based on these data new targets for prevention of pharmacoresistance have been suggested. Different chronic epilepsy models are established in the institute including models with spontaneous seizures. A unique digital video-EEG monitoring unit allows simultaneous recordings from 16 animals and renders the basis for efficient pharmacological testing in these models. Thereby, established protocols which allow the selection of pharmacoresistant animals render the tool for proof-of-principle studies of radioligands within the consortium. Moreover, the strong background in immunohistochemistry and the excellent equipment for optical imaging (e.g. incl. confocal laser scanning microscopy, Microbrightfield system for unbiased stereology) allows the precise determination of the expression of transporters and other molecules of interest.